See also References for pregnancy information (2023) "Product Information
The FDAs approval of GLP-1 receptor agonists for type 2 diabetes mellitus and obesity, principally supported by their cardiovascular benefits, 12,13 raised interest in their potential role in treating MASH
The drug is not available for self-administration or home storage
Therefore, inactivation of NHE3 can result in natriuresis
However, those with a BMI of 27 or higher may also be eligible if they have related medical conditions like type 2 diabetes, hypertension, high cholesterol, or obstructive sleep apnea
These could indicate serious conditions such as pancreatitis or gallbladder disease, which require immediate assessment